uniQure QURE Enterprise value

Enterprise value at other companies

Sarepta Therapeutics, Inc.SRPT

$1.52B-2.9%

Taysha Gene Therapies, Inc.TSHA

$1.08B+368%

PTC TherapeuticsPTCT

$5.2B+77.3%

Design Therapeutics, Inc.DSGN

$646.16M+211%

Candel Therapeutics, Inc.CADL

$166.92M-10.1%

RegenxbioRGNX

$651.8M+51.8%

FAQ

What is uniQure's enterprise value?

uniQure (QURE) reported enterprise value of $2.82B in Q2 2026.

How has uniQure's enterprise value changed year-over-year?

uniQure's enterprise value increased by 376.2% year-over-year, from $591.44M to $2.82B.

What is the long-term trend for uniQure's enterprise value?

Over 5 years (2020 to 2025), uniQure's enterprise value has grown at a -0.3% compound annual growth rate (CAGR), from $1.5B to $1.47B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.